Abbott Laboratories
NYSE:ABT
Abbott Laboratories
Total Liabilities
Abbott Laboratories
Total Liabilities Peer Comparison
Competitive Total Liabilities Analysis
Latest Figures & CAGR of Competitors
Company | Total Liabilities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Abbott Laboratories
NYSE:ABT
|
Total Liabilities
$34.6B
|
CAGR 3-Years
-5%
|
CAGR 5-Years
-1%
|
CAGR 10-Years
7%
|
|
Becton Dickinson and Co
NYSE:BDX
|
Total Liabilities
$26.9B
|
CAGR 3-Years
-4%
|
CAGR 5-Years
-3%
|
CAGR 10-Years
15%
|
|
Boston Scientific Corp
NYSE:BSX
|
Total Liabilities
$15.9B
|
CAGR 3-Years
1%
|
CAGR 5-Years
5%
|
CAGR 10-Years
5%
|
|
Edwards Lifesciences Corp
NYSE:EW
|
Total Liabilities
$2.7B
|
CAGR 3-Years
1%
|
CAGR 5-Years
4%
|
CAGR 10-Years
9%
|
|
Stryker Corp
NYSE:SYK
|
Total Liabilities
$21.3B
|
CAGR 3-Years
0%
|
CAGR 5-Years
7%
|
CAGR 10-Years
12%
|
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
Total Liabilities
$2.1B
|
CAGR 3-Years
14%
|
CAGR 5-Years
13%
|
CAGR 10-Years
17%
|
See Also
What is Abbott Laboratories's Total Liabilities?
Total Liabilities
34.6B
USD
Based on the financial report for Dec 31, 2023, Abbott Laboratories's Total Liabilities amounts to 34.6B USD.
What is Abbott Laboratories's Total Liabilities growth rate?
Total Liabilities CAGR 10Y
7%
Over the last year, the Total Liabilities growth was -8%. The average annual Total Liabilities growth rates for Abbott Laboratories have been -5% over the past three years , -1% over the past five years , and 7% over the past ten years .